Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Cervical Cancer

Free Subscription 14.09.2026 1 ACS Appl Mater Interfaces 1 Acta Obstet Gynecol Scand 1 Acta Paediatr 1 Afr J Lab Med 1 Am J Cancer Res 1 Arch Acad Emerg Med 2 BMC Public Health 1 BMC Womens Health 1 BMJ Open 3 Brachytherapy 1 Can Vet J 1 Cancer 1 Cancer Causes Control 1 Cancer Chemother Pharmacol 1 Cancer Med 1 Cancer Treat Res Commun 1 Chirurgia (Bucur) 2 Cureus 1 Diagn Microbiol Infect Dis 1 Elife 1 Eur J Med Chem 2 F1000Res 2 Front Immunol 1 Front Med (Lausanne) 4 Front Oncol 2 Front Public Health 1 Gynecol Oncol 1 Hum Cell 2 Hum Vaccin Immunother 1 Infect Genet Evol 5 Int J Gynecol Cancer 1 Int J Health Plann Manage 1 Int J Hyperthermia 1 Int J Surg Pathol 1 Int Urogynecol J 1 J Gynecol Obstet Hum Reprod 2 J Gynecol Oncol 1 J Med Imaging Radiat Oncol 1 J Obstet Gynaecol Res 1 JAMA Oncol 1 Lancet Reg Health Eur 1 Magy Onkol 1 Narra J 1 Oncol Lett 1 Oncol Rev 1 Open Forum Infect Dis 3 PLoS One 1 Prev Med 1 Public Health Chall 1 Public Health Nurs 1 Sci Prog 4 Transl Cancer Res 1 Trends Cancer 1 Vaccine 1 Womens Health (Lond) 1 Zhong Nan Da Xue Xue Bao Yi Xue Ban 1 Zhonghua Fu Chan Ke Za Zhi

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

ACS Appl Mater Interfaces

1. ARNHOLDT M, Awakowicz L, Kogelheide B, Boddecker A, et al
   Preclinical Characterization of Dielectric Barrier Discharge as a Complementary Plasma Technology for Low-Thermal Argon Plasma Devitalization of Cervical Intraepithelial Neoplasia.
   ACS Appl Mater Interfaces. 2026;18:47542-47554.
   PubMed         Abstract available
   
   

   
   Acta Obstet Gynecol Scand

2. AHMED F, Bibi M, Gulfishan S, Raza A, et al
   Methodological considerations in the implementation of HPV self-sampling for cervical cancer screening.
   Acta Obstet Gynecol Scand. 2026 Sep 6:10.1111/aogs.70356.
   PubMed        
   
   

   
   Acta Paediatr

3. DILLNER J
   Optimising Human Papillomavirus Vaccination Strategies for Faster Cervical Cancer Elimination.
   Acta Paediatr. 2026 Sep 5. doi: 10.1111/apa.70756.
   PubMed         Abstract available
   
   

   
   Afr J Lab Med

4. CHEGE MN, Kang'ethe S, Kimani SN
   Evaluation of visual inspection with acetic acid and Pap smear tests in early cervical cancer screening among women in Meru County, Kenya.
   Afr J Lab Med. 2026;15:3054.
   PubMed         Abstract available
   
   

   
   Am J Cancer Res

5. GUO L, Li C, Guo J, Qiu J, et al
   Erratum: CKAP2 promotes cervical cancer progression by modulating the tumor microenvironment via NF-kappaB signaling.
   Am J Cancer Res. 2026;16:3750-3752.
   PubMed         Abstract available
   
   

   
   Arch Acad Emerg Med

6. HORAMEE STA, Hosseini M, Arabpour M, Modarressi MH, et al
   Diagnostic Accuracy of DNA Methylation Markers for Detecting Cervical Precancer and Cervical Cancer: A Systematic Review and Meta-analysis.
   Arch Acad Emerg Med. 2026;14:e37.
   PubMed         Abstract available
   
   

   
   BMC Public Health

7. ADEWOLE IE, Akinsolu FT, Abodunrin OR, Lukwa AT, et al
   HPV vaccine awareness, perceptions, uptake, and school-based information channels during Nigeria's national rollout: a cross-sectional study among adolescent girls in rural Oyo State.
   BMC Public Health. 2026;26:2579.
   PubMed         Abstract available
   
   
8. KIGONGO E, Heaney C, McBride L, Gliga G, et al
   A global scoping review of interventions to increase participation in screening programmes for breast, cervical and colorectal cancer between 2016 and 2025.
   BMC Public Health. 2026;26:2549.
   PubMed         Abstract available
   
   

   
   BMC Womens Health

9. GENG T, Li S, Bian Y, Li X, et al
   Association of PAX1/JAM3 gene methylation, HR-HPV, and TCT with high-grade cervical lesions in a high-risk cohort: a multinomial logistic regression analysis.
   BMC Womens Health. 2026;26:447.
   PubMed         Abstract available
   
   

   
   BMJ Open

10. NICHOL B, Bryant A, Hall L, von Wagner C, et al
    Behaviourally informed text message reminders to increase cervical screening attendance in people with severe mental illness: the OPTIMISE pilot randomised controlled trial.
    BMJ Open. 2026;16:e122934.
    PubMed         Abstract available
    
    

    
    Brachytherapy

11. BAJWA HK, Beriwal S, Natte R, Sherin R, et al
    Outcomes of single application and three fraction hybrid MR adaptive brachytherapy in Carcinoma Cervix-Early experience from an Indian cancer center.
    Brachytherapy. 2026;25:736-740.
    PubMed         Abstract available
    
    
12. BABAIE M, Aghili M, Poudineh M, Bayani R, et al
    Short course versus conventional interventional radiotherapy (brachytherapy) regimen in locally advanced cervical cancer: A randomized clinical trial.
    Brachytherapy. 2026 Sep 10:S1538-4721(26)00268.
    PubMed         Abstract available
    
    
13. RANI VV, Vasavi G, Reddy KVSP
    Comment on "Radiomics-based machine-learning approach to predict response at brachytherapy using pretreatment magnetic resonance imaging in locally advanced cervical cancer".
    Brachytherapy. 2026;25:882-883.
    PubMed        
    
    

    
    Can Vet J

14. YAMAZAKI H, Yamamoto S, Sakai T, Hanazono K, et al
    Primary vaginal T-cell lymphoma involving the cervix in 2 dogs.
    Can Vet J. 2026;67:982-989.
    PubMed         Abstract available
    
    

    
    Cancer

15. MAZZITELLI N, Star J, Meggett K, Han X, et al
    Prevalence of breast, cervical, and colorectal cancer screening among adults according to disability type and difficulty level, United States, 2021 and 2023.
    Cancer. 2026;132:e70557.
    PubMed         Abstract available
    
    

    
    Cancer Causes Control

16. LIN YC, Hume E, Boxtha C, Commaroto SA, et al
    Predictors of anal and cervical cancer screening uptake among adults with and without HIV: survey of a community-based health clinic network.
    Cancer Causes Control. 2026;37:159.
    PubMed         Abstract available
    
    

    
    Cancer Chemother Pharmacol

17. MODI A, Parida BP, Pradhan S, Singh S, et al
    LiCl induces GSK-3beta mediated autophagy, DNA damage, and cell cycle arrest in HPV driven cervical cancer cells.
    Cancer Chemother Pharmacol. 2026;96:99.
    PubMed         Abstract available
    
    

    
    Cancer Med

18. ROBINSON EW, Murphy EA, Albanez A, Tulsyan S, et al
    STK11 Mutations and Deletions Define an Aggressive Molecular Subgroup of Cervical Adenocarcinoma.
    Cancer Med. 2026;15:e72228.
    PubMed         Abstract available
    
    

    
    Cancer Treat Res Commun

19. BILAN F, Jafari B, Gharesouran J, Kiani Darabi AH, et al
    Long non-coding RNAs as biomarkers for diagnosis and prognosis in HPV-associated cervical cancer: A systematic scoping review.
    Cancer Treat Res Commun. 2026;49:101437.
    PubMed         Abstract available
    
    

    
    Chirurgia (Bucur)

20. ANGHEL B, Manea E, Scripcariu V, Georgescu TF, et al
    Vaginal Morbidity and Quality of Life after CT-Guided Hybrid Brachytherapy for Locally Advanced Cervical Cancer.
    Chirurgia (Bucur). 2026;121:423-431.
    PubMed         Abstract available
    
    

    
    Cureus

21. DAS P, Deepthi GV, Chevireddy P, Subramanian BV, et al
    Prospective Assessment of Short-Term Response and Acute Toxicity With Accelerated Fractionation Radiotherapy Versus Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer.
    Cureus. 2026;18:e114053.
    PubMed         Abstract available
    
    
22. TOSKA A, Georga D, Latsou D, Fradelos EC, et al
    Preliminary Validation of the Greek Version of the Cervical Cancer Prevention Knowledge (CCKP) Questionnaire.
    Cureus. 2026;18:e113985.
    PubMed         Abstract available
    
    

    
    Diagn Microbiol Infect Dis

23. ROTTERDAM GFS, Campelo SM, Laurentino RV, Carneiro SR, et al
    High prevalence of HPV and high levels of oxidative stress in asymptomatic mature women in the Amazon: a pilot study.
    Diagn Microbiol Infect Dis. 2026;116:117620.
    PubMed         Abstract available
    
    

    
    Elife

24. VAN ARSDALE AR, Meshcheryakova O, Gallego S, Maggi EC, et al
    Serum, cell-free, HPV-human DNA junction detection and HPV typing for predicting and monitoring cervical cancer recurrence.
    Elife. 2026;14:RP105741.
    PubMed         Abstract available
    
    

    
    Eur J Med Chem

25. WANG W, Shayilan N, Qi X, Ma C, et al
    Design, synthesis, and screening of novel thienopyrimidine derivatives as PI3K/HDAC dual inhibitors against cervical cancer cells.
    Eur J Med Chem. 2026;320:119315.
    PubMed         Abstract available
    
    

    
    F1000Res

26. KRISHNA A, Lobo JL, Ms P, Makkapati BS, et al
    Evaluation and Clinical Relevance of Plan Quality Indices in Intracavitary Brachytherapy for Cervical Cancer.
    F1000Res. 2026;14:882.
    PubMed         Abstract available
    
    
27. ONISHI T, Miyamoto T, Osawa Y, Shibahara K, et al
    Dataset of multi-focus (Z-stack) images derived from liquid-based cervical cancer cytology specimens.
    F1000Res. 2026;15:502.
    PubMed         Abstract available
    
    

    
    Front Immunol

28. SCHELLEKENS HCJ, Bindels BJR, Regueiro Zapico I, Morre SA, et al
    Microbiome-host interactions in locally advanced cervical cancer: the impact on chemoradiotherapy treatment outcomes and toxicity.
    Front Immunol. 2026;17:1876914.
    PubMed         Abstract available
    
    
29. TIAN Y, Chang H, Liu J, Ding W, et al
    Building bridges to immunotherapy: a knowledge-mapping analysis of cervical cancer organoid research.
    Front Immunol. 2026;17:1788725.
    PubMed         Abstract available
    
    

    
    Front Med (Lausanne)

30. TASTAN M, Ersoy Sen B, Yilmaz M
    Factors affecting women's participation in cervical cancer screening through the theory of planned behavior: a cross- sectional study in Turkiye.
    Front Med (Lausanne). 2026;13:1910126.
    PubMed         Abstract available
    
    

    
    Front Oncol

31. RAHMAN MA, Bhuiyan MTA, Khan MFI, Uddin MZ, et al
    Integrating domain-specific convolutional features with Swin Transformers for transparent cervical cancer diagnostics.
    Front Oncol. 2026;16:1878677.
    PubMed         Abstract available
    
    
32. TSOGTGEREL NE, Adiyadorj D, Ganbaatar GE, Parry AE, et al
    Trends in cervical cancer incidence and mortality in Mongolia, 2014-2024: a population-based analysis of pandemic-related disruptions.
    Front Oncol. 2026;16:1853617.
    PubMed         Abstract available
    
    
33. LIU S, Yang T, Chu A, Sun C, et al
    VCAN is upregulated in the cervical cancer stroma and modulates macrophage polarization.
    Front Oncol. 2026;16:1902341.
    PubMed         Abstract available
    
    
34. YORDANOV AD, Tsoneva E, Dimitrova PD, Kostov SG, et al
    Unsupervised 20-feature immunohistochemical immune profiling identifies exploratory cervical cancer phenotypes with unfavorable survival signals.
    Front Oncol. 2026;16:1914836.
    PubMed         Abstract available
    
    

    
    Front Public Health

35. LIU Y, Zhao K, Sun W, Jiang N, et al
    Limited discriminant validity of health belief and 3C models in high HPV vaccine coverage settings: the moderating role of hukou and structural barriers.
    Front Public Health. 2026;14:1903410.
    PubMed         Abstract available
    
    
36. WANG K, Ma X, Wang H
    A latent profile analysis of the pain-fatigue-sleep disturbance symptom clusters in postoperative cervical cancer patients: a multicenter cross-sectional study.
    Front Public Health. 2026;14:1901928.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol

37. DENG L, Zheng Y, Yang F, Wang Q, et al
    Minimally invasive surgery without a uterine manipulator versus open radical hysterectomy for early-stage cervical cancer: A retrospective propensity-score-matched single-center cohort study.
    Gynecol Oncol. 2026;213:41-49.
    PubMed         Abstract available
    
    

    
    Hum Cell

38. ZHANG Y, Li W, Zhuo Q, Abuduwufu S, et al
    GMPS promotes cervical squamous cell carcinoma cell immune evasion through USP7-mediated deubiquitination of PDL1.
    Hum Cell. 2026;39:135.
    PubMed         Abstract available
    
    

    
    Hum Vaccin Immunother

39. LUBANGA AF, Nyasulu W, Stande M, Kamanga M, et al
    Protect her future: Lessons learned from a school and community engagement initiative for HPV vaccine awareness in Lilongwe, Malawi.
    Hum Vaccin Immunother. 2026;22:2727812.
    PubMed         Abstract available
    
    
40. PUNGARTNIK PC, Parellada CI, Mayumi Usuda Prado Rocha D, Queijo RG, et al
    Premature mortality and years of potential productive life lost due to HPV-attributable cancers in Brazil and Mexico: 2011 Versus 2023.
    Hum Vaccin Immunother. 2026;22:2728247.
    PubMed         Abstract available
    
    

    
    Infect Genet Evol

41. LI M, Zhang T, Shen Z, Zhang X, et al
    Molecular epidemiology and phylogeographic architecture of oncogenic intracellular bacteria in cervical cancer patients across Northern China.
    Infect Genet Evol. 2026;144:106016.
    PubMed         Abstract available
    
    

    
    Int J Gynecol Cancer

42. ARROYO MUHR LS, Mungo C, Chatzistamatiou K, Leung SOA, et al
    International Papillomavirus Society statement on reputed treatments for human papillomavirus infection and human papillomavirus-related diseases: evidence, risks, and standards for clinical evaluation.
    Int J Gynecol Cancer. 2026;36:104950.
    PubMed         Abstract available
    
    
43. KABIRIAN R, de Saint Ghislain M, Le Saux O, Mathiot L, et al
    Efficacy and safety of immune checkpoint inhibitor rechallenge in cervical and endometrial cancer: a multi-center retrospective study (RICE study).
    Int J Gynecol Cancer. 2026;36:104867.
    PubMed         Abstract available
    
    
44. PLANTE M, Kwon JS, Mahner S, Cormier B, et al
    Correlation of pelvic magnetic resonance imaging with diagnostic loop electrosurgical excision procedure/cone biopsy and hysterectomy pathology: an exploratory analysis of the CX.5/SHAPE trial.
    Int J Gynecol Cancer. 2026;36:104835.
    PubMed         Abstract available
    
    
45. CLARK HD, Frumovitz M, Rangel KM, Li Z, et al
    Cadonilimab for recurrent small cell neuroendocrine carcinoma of the cervix: a phase 2 study.
    Int J Gynecol Cancer. 2026;36:104860.
    PubMed         Abstract available
    
    
46. PAREJA R, Heredia F, Sanchez-Diaz E, Cuello MA, et al
    FIGO/IGCS Statement on the efficacy of topical treatments for high-risk human papillomavirus in preventing CIN 3+ lesions.
    Int J Gynecol Cancer. 2026;36:104946.
    PubMed         Abstract available
    
    

    
    Int J Health Plann Manage

47. NDOUR AA, Malham SA, Milot DM, Baron G, et al
    Barriers and Facilitators to the Implementation of the Weekend-70 Cervical Cancer Screening Programme in Mali: A Multiple Case Study.
    Int J Health Plann Manage. 2026 Sep 9. doi: 10.1002/hpm.70136.
    PubMed         Abstract available
    
    

    
    Int J Hyperthermia

48. BAI L, Li F, Liu S, Shi F, et al
    Hyperthermia sensitizes cervical cancer to chemoradiotherapy by downregulating c-Myc/WSB1/beta-catenin expression.
    Int J Hyperthermia. 2026;43:2713197.
    PubMed         Abstract available
    
    

    
    Int J Surg Pathol

49. BAHMAD HF
    Challenges in Assessing Stromal Invasion and Staging Cervical Carcinomas Arising In or Confined to Endocervical Polyps.
    Int J Surg Pathol. 2026;34:1701-1712.
    PubMed         Abstract available
    
    

    
    Int Urogynecol J

50. SHI Y, Sherryn S, Wang S, Lei Z, et al
    Palliative Management of Inoperable Vesicovaginal Fistula in Cervical Cancer Patient Using Bilateral Single-J Stents and Bladder Stoma: A Pilot Study.
    Int Urogynecol J. 2026 Sep 11. doi: 10.1007/s00192-026-06890.
    PubMed         Abstract available
    
    

    
    J Gynecol Obstet Hum Reprod

51. CHLALA W, Favier A, Carcopino X, Canlorbe G, et al
    INITIAL EVALUATION OF CERVICAL CANCER: A LITERATURE REVIEW OF STAGING CONIZATION FOR ACCURATE RISK STRATIFICATION AND GUIDANCE OF PRIMARY TREATMENT IN EARLY-STAGE DISEASE - A REVIEW FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP.
    J Gynecol Obstet Hum Reprod. 2026 Sep 8:103274. doi: 10.1016/j.jogoh.2026.103274
    PubMed         Abstract available
    
    

    
    J Gynecol Oncol

52. MA C, Yin P, Hong N
    Long-term trends and future projections of cervical cancer burden in China, 1990-2023: a Global Burden of Disease 2023 analysis.
    J Gynecol Oncol. 2026 Aug 24. doi: 10.3802/jgo.2027.
    PubMed         Abstract available
    
    
53. CHIKAZAWA K, Ozawa R, Kuwata T
    Who should participate in laparoscopic surgery trials for early cervical cancer? Surgeon authority and selection bias in randomized studies of open versus minimally invasive surgery for early-stage cervical cancer.
    J Gynecol Oncol. 2026 Aug 28. doi: 10.3802/jgo.2027.
    PubMed        
    
    

    
    J Med Imaging Radiat Oncol

54. EDWARDS L, Tan H, Rahim K, Leong E, et al
    MRI-Guided SBRT Boost for Patients With Locally Advanced Cervical Cancer Who Are Unsuitable for Standard of Care Image-Guided Brachytherapy.
    J Med Imaging Radiat Oncol. 2026 Sep 12. doi: 10.1111/1754-9485.70185.
    PubMed         Abstract available
    
    

    
    J Obstet Gynaecol Res

55. SHIMIZU A, Chikazawa K, Fukuda Y, Imai K, et al
    Real-World Outcomes of Weekly Paclitaxel-Carboplatin-Based Chemoradiotherapy Versus Cisplatin-Based Chemoradiotherapy for FIGO Stage IB2-IVA Cervical cancer: A Retrospective Observational Study.
    J Obstet Gynaecol Res. 2026;52:e70489.
    PubMed         Abstract available
    
    

    
    JAMA Oncol

56. HASEGAWA K, Colombo N, Tewari KS, Dubot C, et al
    Pembrolizumab Plus Chemotherapy for Cervical Cancer: An Exploratory Analysis of the KEYNOTE-826 Randomized Clinical Trial.
    JAMA Oncol. 2026 Sep 10:e263547. doi: 10.1001/jamaoncol.2026.3547.
    PubMed         Abstract available
    
    

    
    Lancet Reg Health Eur

57. BAFFOUR AWUAH G, Fett S, Schauberger G, Osmani V, et al
    The effect of HPV vaccination on precancerous lesions and invasive cervical cancer in a low-vaccination-coverage setting in Germany: a retrospective cohort analysis.
    Lancet Reg Health Eur. 2026;69:101830.
    PubMed         Abstract available
    
    

    
    Magy Onkol

58. BAHREHMAND K, Fabian T, Kerepesi J, Novak Z, et al
    [The role of sentinel lymph node biopsy in the management of gynecologic cancers: current evidence and institutional experience].
    Magy Onkol. 2026;70:269-276.
    PubMed         Abstract available
    
    

    
    Narra J

59. SUBANDI S, Aisyah ON, Lestari B
    Nanoliposomal curcumin as a potential pro-apoptotic agent for cervical cancer: Evidence from Bcl-2 and Bax modulation in HeLa cells.
    Narra J. 2026;6:e3126.
    PubMed         Abstract available
    
    

    
    Oncol Lett

60. ZOU Y, Huang R, Qin W, Wu C, et al
    Pre-radiotherapy modified prognostic nutritional index predicts acute radiation enteritis in patients with cervical cancer undergoing radiotherapy: A retrospective study.
    Oncol Lett. 2026;32:471.
    PubMed         Abstract available
    
    

    
    Oncol Rev

61. HAN B, Liang M, Qi D, Qu Y, et al
    Brucea javanica oil emulsion as an adjunct to chemoradiotherapy in cervical cancer: a systematic review and meta-analysis of adverse effects reduction and immune enhancement.
    Oncol Rev. 2026;20:1880668.
    PubMed         Abstract available
    
    

    
    Open Forum Infect Dis

62. CEESAY E, Avala Ntsigouaye J, Onwuka JU, Shanshan Y, et al
    Integrating Cervical Cancer Prevention into HIV Services in Sub-Saharan Africa: A Narrative Review Addressing the Dual Burden Among Women.
    Open Forum Infect Dis. 2026;13:ofag509.
    PubMed         Abstract available
    
    

    
    PLoS One

63. SPENCER ER, Winer RL, Ba S, Sy MP, et al
    Impact of menopausal status on human papillomavirus detection and cervical neoplasia in middle-aged Senegalese women.
    PLoS One. 2026;21:e0358080.
    PubMed         Abstract available
    
    
64. SPRINGE L, Kivite-Urtane A, Tihomirova L, Stars I, et al
    Women's compliance with cervical cancer screening recommendations and associated barriers to participation: A cross-sectional analysis.
    PLoS One. 2026;21:e0357819.
    PubMed         Abstract available
    
    
65. EFFAH K, Tekpor E, Afetor M, Amuah JE, et al
    Cervical leukoplakia in Ghana: Unveiling diagnostic challenges and informing low-resource screening strategies.
    PLoS One. 2026;21:e0345847.
    PubMed         Abstract available
    
    

    
    Prev Med

66. WANG H, Ma H, Li R, Wang M, et al
    From human papillomavirus (HPV) infection to HPV-associated cancers in systemic lupus erythematosus: A systematic review and Meta-analysis.
    Prev Med. 2026;212:108641.
    PubMed         Abstract available
    
    

    
    Public Health Chall

67. NEETHLING GS, Razack R, Botha MHH
    From Pap Test to Treatment: Assessing Facility Level Gaps in Cervical Cancer Care in Cape Town.
    Public Health Chall. 2026;5:e70360.
    PubMed         Abstract available
    
    

    
    Public Health Nurs

68. FERRELL CD, Hall KC, Reaves S, Wentzensen N, et al
    Why Women Don't Return: Nurse Perspectives on Follow-Up Care After Abnormal Cervical Cancer Screening Results in Mississippi's Public Health System.
    Public Health Nurs. 2026 Sep 12. doi: 10.1111/phn.70186.
    PubMed         Abstract available
    
    

    
    Sci Prog

69. WU A, Rezhake R, Huang Z, Abulizi G, et al
    Association of regional lymph node resection with survival in patients with locally advanced-stage cervical cancer: A retrospective SEER-based cohort study.
    Sci Prog. 2026;109:368504261481941.
    PubMed         Abstract available
    
    

    
    Transl Cancer Res

70. KANG Y, Huang Y, Chen Y, Osafo KS, et al
    Hypoxia-inducible factor-1alpha promotes the malignant progression of cervical cancer cells by regulating lactate dehydrogenase A-mediated glycolysis.
    Transl Cancer Res. 2026;15:632.
    PubMed         Abstract available
    
    
71. QI T, Yang J, Abulizi G
    CEBPG demonstrates oncogene functions and modulates the expression of genes involved in cervical cancer related pathways.
    Transl Cancer Res. 2026;15:593.
    PubMed         Abstract available
    
    
72. YU H, Xiu Y, Meng F, He H, et al
    A three-gene radioresistance signature predicts tumor progression in cervical cancer.
    Transl Cancer Res. 2026;15:577.
    PubMed         Abstract available
    
    
73. WENG C, Wang Y, Chen W, Chen S, et al
    Survival outcomes of postoperative radiotherapy and chemotherapy in early-stage cervical cancer: a Surveillance, Epidemiology, and End Results database-based stratified analysis.
    Transl Cancer Res. 2026;15:572.
    PubMed         Abstract available
    
    

    
    Trends Cancer

74. WHITE EA
    Lightning doesn't strike twice in HPV-positive adenosquamous carcinoma.
    Trends Cancer. 2026;12:796-797.
    PubMed         Abstract available
    
    

    
    Vaccine

75. PAVIA G, Quirino A, Marascio N, Licata F, et al
    Human papillomavirus (HPV) Vaccination programmes across European countries: time-harmonized coverage among adolescent females, socioeconomic predictors, and impact on public interest.
    Vaccine. 2026;91:129058.
    PubMed         Abstract available
    
    

    
    Womens Health (Lond)

76. FRANS SO, Utomo A, Bennett LR
    Exploring Indonesian midwives' training experiences and knowledge related to cervical screening and HPV DNA testing in East Nusa Tenggara province.
    Womens Health (Lond). 2026;22:17455057261487155.
    PubMed         Abstract available
    
    

    
    Zhong Nan Da Xue Xue Bao Yi Xue Ban

77. CHENG T, Deng L, Liang Z, Tang D, et al
    HAR-Net: Automatic delineation of clinical target volumes for cervical cancer guided by hierarchical anatomical refinement.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2026;51:1077-1097.
    PubMed         Abstract available
    
    

    
    Zhonghua Fu Chan Ke Za Zhi

78. CHEN F, Ruan HJ, Chen XY, Wang Y, et al
    [Efficacy and safety of hexaminolevulinate photodynamic therapy for CIN2].
    Zhonghua Fu Chan Ke Za Zhi. 2026;61:649-657.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum